RxDoctor Payments Data

Yen Wang, MD

Dermatology · Los Angeles, CANPI 1013206945

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $19,528 of the $24,907 with a category attached, or 78.4%. It is spread thinly across 30 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Among dermatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,907in general payments, 2019–2025

Across 845 payments — averaging $29.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EPI Health, LLC$4K
  • AbbVie$4K
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$3K
  • Sun Pharmaceutical Industries Inc.$2K
  • Galderma Laboratories, L.p.$2K
  • Incyte Corporation$1K
  • plus $9K from 24 others
$88,189in research payments, 2019–2025

Across 83 payments — averaging $1062.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mindera Corp$38K
  • Dermavant Sciences, Inc.$20K
  • Eli Lilly$14K
  • Incyte Corporation$8K
  • Taro Pharmaceuticals USA, Inc.$8K

What the payments were for

  • Consulting fees$1,8007%
  • Speaking & faculty fees$3,02212%
  • Travel & lodging$3721%
  • Food & beverage$19,52878%
  • Education$1851%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,907 in reported general payments places this provider in the 90th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$230,179
Medicare patients
195
Services billed
1,501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate12$1,658
Tretinoin11$512
Ketoconazole18$508
Triamcinolone Acetonide21$381
Minoxidil17$213
Mometasone Furoate17$187

Paid to pharmacies, not to this prescriber.

Other dermatology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →